1. Home
  2. ISPC vs AEMD Comparison

ISPC vs AEMD Comparison

Compare ISPC & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

N/A

Current Price

$1.16

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

N/A

Current Price

$6.60

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ISPC
AEMD
Founded
2009
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
2.1M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ISPC
AEMD
Price
$1.16
$6.60
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $13.25
AVG Volume (30 Days)
486.6K
★ 2.7M
Earning Date
11-16-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 87.03
N/A
EPS
N/A
★ N/A
Revenue
★ $1,928,998.00
N/A
Revenue This Year
$638.10
N/A
Revenue Next Year
$17.50
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.10
$0.51
52 Week High
$6.77
$9.50

Technical Indicators

Market Signals
Indicator
ISPC
AEMD
Relative Strength Index (RSI) 27.64 73.01
Support Level $0.27 $1.64
Resistance Level $1.94 $9.50
Average True Range (ATR) 0.09 0.67
MACD 0.01 0.17
Stochastic Oscillator 6.29 61.24

Price Performance

Historical Comparison
ISPC
AEMD

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: